Business ❯ Pharmaceutical Industry

Investment

Research and Development Manufacturing Market Trends Market Dynamics Market Conditions AstraZeneca UK Market NHS Spending Foreign Investment Market Opportunities

Boehringer Ingelheim Transfers CT-155 Commercial Rights to Click Therapeutics With $50 Million Backing

The move positions Click to seek FDA clearance for a software therapy that targets schizophrenia’s untreated negative symptoms.

Brazil Weighs Tirzepatide Access: New Bill Seeks Farmácia Popular Coverage as Patent‑Break Push Advances

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

Mexican Court Revives Denosumab Patent, Extends Amgen Exclusivity to 2027

Brazil Government Opposes Patent Breaks for Weight-Loss Pens After House Fast-Tracks Bill

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

GSK Chief Says U.S. Is Best Place to Invest as UK Softens Drug Pricing Rules

UK Cuts NHS Rebate on New Branded Drugs to 14.5% for 2026 Under US Trade Framework

U.S. and U.K. Seal Three-Year Zero‑Tariff Pharma Deal Tied to Higher NHS Drug Prices

Novartis to Build Radioligand Therapy Plant in Halle by 2027

UK Proposes 25% Rise in NICE Threshold to Avert Trump Tariffs

Trump Jokes About COVID After RFK Jr. Coughs at Oval Office Pfizer Event

Moderna Opens UK’s First Onshore mRNA Vaccine Plant at Harwell

UK Signals Openness to Higher NHS Drug Prices After Pharma Backlash

GSK Pledges $30 Billion U.S. Investment as UK Drug-Pricing Standoff Drives Pullbacks

BMS, BioNTech Small-Cell Lung Cancer Drug Posts 76% Tumor Reduction, Advances to Phase III

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

Grupo Collins Begins Regional Exports, Leveraging GMP Credentials And Jalisco Scale

FDA Launches PreCheck to Accelerate U.S. Drug Manufacturing Approvals

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge